A Phase 2 Study of Tarlatamab in Patients With Small Cell Lung Cancer (SCLC)

PHASE2Active, not recruitingINTERVENTIONAL
Enrollment

222

Participants

Timeline

Start Date

December 1, 2021

Primary Completion Date

April 30, 2026

Study Completion Date

April 30, 2027

Conditions
Relapsed/Refractory Small Cell Lung Cancer
Interventions
DRUG

Tarlatamab

Intravenous (IV) infusion

Trial Locations (80)

1211

Hopitaux Universitaires de Geneve, Geneva

2100

Rigshospitalet, Copenhagen

3000

Universitair Ziekenhuis Leuven - Campus Gasthuisberg, Leuven

3500

Universitaetsklinikum Krems, Krems

5020

Landeskrankenhaus Salzburg, Salzburg

6060

Grand Hopital de Charleroi - Site Saint Joseph, Gilly

9000

Universitair Ziekenhuis Gent, Ghent

10408

National Cancer Center, Goyang-si Gyeonggi-do

11217

Taipei Veterans General Hospital, Taipei

11526

Henry Dunant Hospital Center, Athens

11527

Sotiria General Hospital, Athens

13620

Seoul National University Bundang Hospital, Seongnam-si, Gyeonggi-do

13915

Centre Hospitalier Universitaire Nord, Marseille

15232

University of Pittsburgh Medical Center Cancer Pavillion, Pittsburgh

18547

Metropolitan Hospital, Athens

19713

Christiana Care Health Services, Newark

21100

Azienda Socio Sanitaria Territoriale dei Sette Laghi Ospedale di Circolo e Fondazione Macchi, Varese

22927

LungenClinic Grosshansdorf GmbH, Großhansdorf

26335

General Hospital of Patras Agios Andreas, Pátrai

26506

West Virginia University Health Sciences Center, Morgantown

27157

Wake Forest Baptist Comprehensive Cancer Research Center, Winston-Salem

27705

Duke University Medical Center, Durham

28041

Hospital Universitario 12 de Octubre, Madrid

28222

Hospital Universitario Puerta de Hierro Majadahonda, Majadahonda

29011

Hospital Regional Universitario de Malaga, Málaga

30332

Winship Cancer Institute, Atlanta

31059

Centre Hospitalier Universitaire de Toulouse - Hopital Larrey, Toulouse

33612

Moffitt Cancer Center, Tampa

35033

Centre Hospitalier Universitaire de Rennes - Hopital Pontchaillou, Rennes

35249

University of Alabama at Birmingham, Birmingham

37203

Sarah Cannon Research Institute, Nashville

43126

Azienda Ospedaliero-Universitaria di Parma, Parma

44106

University Hospitals Cleveland Medical Center, Cleveland

45242

Oncology Hematology Care Inc, Cincinnati

46026

Hospital Universitari i Politecnic La Fe, Valencia

48202

Henry Ford Health System, Detroit

50937

Universitaetsklinikum Koeln, Cologne

52242

University of Iowa, Iowa City

54007

Theagenion Cancer Hospital, Thessaloniki

54645

Euromedica General Clinic of Thessaloniki, Thessaloniki

55236

Agios Loukas Clinic, Thessaloniki

67091

Centre Hospitalier Universitaire de Strasbourg - Nouvel Hopital Civil, Strasbourg

69495

Centre Hospitalier Lyon Sud, Pierre-Bénite

71500

University Hospital of Heraklion, Heraklion - Crete

72205

University of Arkansas for Medical Sciences, Little Rock

75248

Institut Curie, Paris

83301

Kaohsiung Chang Gung Memorial Hospital, Kaohsiung City

94805

Institut Gustave Roussy, Villejuif

97078

Universitaetsklinikum Wuerzburg, Würzburg

168583

National Cancer Centre Singapore, Singapore

02215

Dana Farber - Harvard Cancer Center, Boston

03756

Dartmouth Hitchcock Medical Center, Hanover

00144

Istituti Fisioterapici Ospitalieri Regina Elena San Gallicano, Rome

464-8681

Aichi Cancer Center, Nagoya

277-8577

National Cancer Center Hospital East, Kashiwa-shi

700-8558

Okayama University Hospital, Okayama

589-8511

Kindai University Hospital, Osakasayama-shi

411-8777

Shizuoka Cancer Center, Sunto-gun

135-8550

The Cancer Institute Hospital of Japanese Foundation for Cancer Research, Koto-ku

641-8510

Wakayama Medical University Hospital, Wakayama

2333 ZA

Leids Universitair Medisch Centrum, Leiden

3015 GD

Erasmus Medisch Centrum, Rotterdam

80-214

Uniwersyteckie Centrum Kliniczne, Gdansk

91-053

Centra Medyczne Medyceusz Sp zoo, Lodz

05-400

Mazowieckie centrum leczenia, Otwock

1500-650

Hospital da Luz, SA, Lisbon

1998-018

Hospital CUF Descobertas, Lisbon

4099-001

Centro Hospitalar Universitario do Porto EPE - Hospital de Santo Antonio, Porto

4100-180

Hospital Cuf porto, Porto

4200-072

Instituto Portugues de Oncologia do Porto Francisco Gentil, EPE, Porto

03722

Yonsei University Health System Severance Hospital, Seoul

05505

Asan Medical Center, Seoul

06351

Samsung medical center, Seoul

06591

The Catholic University of Korea Seoul St Marys Hospital, Seoul

08035

Hospital Universitari Vall d Hebron, Barcelona

08036

Hospital Clinic i Provincial de Barcelona, Barcelona

08041

Hospital de la Santa Creu i Sant Pau, Barcelona

08908

Instituto Catalan de Oncologia Hospital Duran i Reynals, L'Hospitalet de Llobregat

W1G 6AD

Sarah Cannon Research Institute UK, London

M20 4BX

Christie Hospital, Manchester

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Amgen

INDUSTRY